[Clinical significance of HDL-cholesterol variations in viral hepatitis].
40 patients suffering from acute viral hepatitis, 18 type A, 18 type B and 4 non-A non-B have been examined. During the acute phase there was a marked reduction in HDL cholesterol (average 4.4) with subsequent steady increase up to 16.6 at the 5th week of disease. A highly significant negative correlation was observed between transaminases and direct bilirubin. There was no correlation with prothrombin activity, phospholipids and albumin. The clinical significance of these data is discussed.
D000293:Adolescent; D000328:Adult; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL; D005260:Female; D006506:Hepatitis A / Q000097:blood* / Q000175:diagnosis; D006509:Hepatitis B / Q000097:blood* / Q000175:diagnosis; D006526:Hepatitis C / Q000097:blood* / Q000175:diagnosis; D006525:Hepatitis, Viral, Human / Q000097:blood*; D006801:Humans; D008075:Lipoproteins, HDL / Q000097:blood*; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D008076:Cholesterol, HDL; D008075:Lipoproteins, HDL; D002784:Cholesterol
Significato clinico delle variazioni del colesterolo HDL in corso di epatite virale.